查看中文
henry.wang@cooley.com
Henry Wang focuses his practice on capital markets and regulatory compliance. Prior to joining Cooley, he has worked at Baker & McKenzie and Paul Hastings' Hong Kong office.
Download full bio
Keymed Biosciences – HK$3.1 Billion IPO
Capital Markets
Mergers & Acquisitions
The University of Chicago Law School LLM, 2017LLM, 2017
National Taipei UniversityLLM, 2014
SooChow UniversityLLB, 2010
Keymed Biosciences – HK$3.1 Billion IPO July 8, 2021
+852 3758 1240
Locations